M

Michael G. Kharas

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-1165-6991

221 papers and 9.4k citations.

PubIndex Score89Top 11% · seniorHow it's scored

221Publications

9.4kTotal Citations

First publication: 2003First senior author: 2007

Top publicationsby citations

Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells

Michael G. Kharas, Matthew R. Janes, Vanessa M. Scarfone et al.|Journal of Clinical Investigation|2008

Cited by 150

Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia

Gerard Minuesa, Michael G. Kharas|Nature Communications|2019

Cited by 146

HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells

Diu Nguyen, Michael G. Kharas|Nature Communications|2020

Cited by 72

TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma

Tatiana Erazo, Michael G. Kharas|Nature Communications|2022

Cited by 28

RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells

Florisela Herrejon Chavez, Michael G. Kharas|Nature Communications|2023

Cited by 20

Indexing the rest of 221 publications…